Education
About Us
Working with TipRanks
Follow Us
Impedimed Limited (IPDQF)
OTHER OTC:IPDQF
IPDQF Stock Chart & Stats
$0.01
<$0.01(23.84%)
At close: 4:00 PM EST
$0.01
<$0.01(23.84%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.06
Previous CloseN/A
Volume1.78K
Average Volume (3M)4.27K
Market Cap
$67.13M
Enterprise Value$63.27M
Total Cash (Recent Filing)$17.69M
Total Debt (Recent Filing)$1.05M
Price to Earnings (P/E)―
Beta2.71
Next Earnings
Oct 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,036,147,500
10 Day Avg. Volume1,598
30 Day Avg. Volume4,268
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue5.48
Enterprise Value/Gross Profit6.24
Enterprise Value/Ebitda-3.00
Forecast
1Y Price Target
$0.07Price Target Upside600.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Impedimed Limited News
IPDQF FAQ
What was Impedimed Limited’s price range in the past 12 months?
Impedimed Limited lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
What is Impedimed Limited’s market cap?
Impedimed Limited’s market cap is $67.13M.
When is Impedimed Limited’s upcoming earnings report date?
Impedimed Limited’s upcoming earnings report date is Oct 30, 2025 which is today.
How were Impedimed Limited’s earnings last quarter?
Impedimed Limited released its earnings results on Aug 27, 2025. The company reported $0 earnings per share for the quarter, beating the consensus estimate of -$0.002 by $0.002.
Is Impedimed Limited overvalued?
According to Wall Street analysts Impedimed Limited’s price is currently Undervalued.
Does Impedimed Limited pay dividends?
Impedimed Limited does not currently pay dividends.
What is Impedimed Limited’s EPS estimate?
Impedimed Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Impedimed Limited have?
Impedimed Limited has 2,036,147,500 shares outstanding.
What happened to Impedimed Limited’s price movement after its last earnings report?
Impedimed Limited reported an EPS of $0 in its last earnings report, beating expectations of -$0.002. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Impedimed Limited?
Currently, no hedge funds are holding shares in IPDQF
Impedimed Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$0.07 (600.00% Upside)
$0.07 (600.00% Upside)
Blogger Sentiment
Bullish
IPDQF Sentiment 85%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.96%
12-Months-Change
Fundamentals
Return on Equity
-74.00%
Trailing 12-Months
Asset Growth
-12.99%
Trailing 12-Months
Company Description
Impedimed Limited
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
IPDQF Company Deck
IPDQF Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong sales growth and increased contract pricing, indicating positive momentum and confidence in the business's future. However, challenges such as the cleanup of the legacy installed base and significant cash outflows were noted, which could impact short-term financial stability.View all IPDQF earnings summariesIPDQF Stock 12 Month Forecast
Average Price Target
$0.07
▲(600.00% Upside)
Technical Analysis
Nova Eye Medical
―
Compumedics Limited
―
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Ownership Overview
0.62% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.38% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---